1)  subcutaneous
下注射
1.
OBJECTIVE To investigate the realtionship among the local pressing time the incidence and the size of subcutaneous hemorrhage,and find a optimum pressing time in order to reduce the incidence and the size of subcutaneous hemorrage after the injection of low molecular weight heparin(LMWH) .
目的探讨低分子肝素皮下注射局部压迫时间与皮下出血发生率及出血面积的关系,同时找出较为有效的压迫时间,以减少皮下出血的发生及减小出血面积。
2)  Subcutaneous injection
皮下注射
1.
Research progress on low molecular heparin subcutaneous injection method;
低分子肝素皮下注射方法研究进展
2.
Observation on subcutaneous injection of EPO at extensor side of elbow joint for patients with anemia;
肘关节伸侧皮下注射重组人红细胞生成素治疗贫血的观察
3.
Subcutaneous injection of plasmid VEGF gene: a method of gene therapy to enhance the viability of random skin flap;
皮下注射血管内皮生长因子基因提高大鼠背部随意皮瓣活力的实验研究
3)  subcutaneous
皮下注射
4)  hypodermic injection
皮下注射
1.
A study on press methods of hypodermic injection of low molecular heparin;
低分子肝素皮下注射按压方法的研究
2.
Health education of hypodermic injection of ins ulin for diabetes patients;
糖尿病患者自行皮下注射胰岛素的健康教育
3.
[Methods] Rats with diabetes were divided into 3 groups: 4 diabetic rats took orally negative oily solution without insulin in blank group; 4 diabetic rats were given hypodermic injection of 2.
方法将糖尿病大鼠分为3大组:空白组:糖尿病大鼠4只,口服不含胰岛素的油溶液;对照组:糖尿病大鼠4只,经皮下注射2。
5)  Sub-eschar injection
痂下注射
6)  sub-Tenon 's capsule injection
筋膜下注射
参考词条
补充资料：113Inm-DTPP注射液
分子式：
CAS号：

性质：又称铟113m二亚乙基三胺无亚甲基膦酸(indium 113Inm diethylenetriamine pentamet-hylenophosphonic acid注射液；113Inm-DTPP)注射液。在无菌操作条件下，氯化铟113m注射液与泮替膦酸注射液反应，得到的无色澄明放射性诊断用药，主要用于骨显像。

说明：补充资料仅用于学习参考，请勿用于其它任何用途。